Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Its all good, Lots of traders under water from the last spike. Its ok, We,re gonna reach all those break even points and all will profit! ACOL$$$$$$$$$$$
Hey FrankMD, Never left, just sat back holding long ACOL..
Its our time!
ACOL 0.10 Coming quick
Good Morning ATPT crew$$$$$$$$$
They come from the shed sometimes ATPT
ATPT$$$ Going up today.. DD solid
ATPT Holding strong $$$$$$$$$$
Stop playin DD.... lol
Open @0.0072 ATPT Pre Market
Well said.. ATPT Great DD
Morning boys, ATPT going up today
You must have not seen 80k worth of filings
QSIM Glad i picked up some more! Going up$$$$$$$$$$$$$$
QSIM$$$$$$$$$$$
17M bidding ATPT
10M @12 Bid ATPT
Abt to pop ATPT
It happened to me a while back when i started without L2. If you make a few trades with Etrade you'll get L2 plus the Pro platform. It helped me alot in learning and expenses. Hope it works for you as well. Good Luck brother
My friend, Stop trading without L2
Its a death wish to do so. Good luck
No one biting the news NECA
Do your own DD :)
Bounce coming though, good chance to get out
lolzz we did
ZNNC Im in $$$$$$$$$$$$$$$
Good work DD_dempsey APHD bounce
ALRT WOW this is insane! $$$$$$$$$$$$$
Holding MNZO
WTF happened here
0.12+ Dollars coming ALRT$$$$$$$$$$$$$$$$
WOW is the MEME ALRT$$$$$$
WOW WOW WOW ALRT$$$
WOW has become a meme for this board today!!!
Cheers!!!
Charger's, Hellcats FOR FREE BOYS ALRT$$$$$$
NOT SELLING CHIT DOLLAR RUNNER+++ ALRT
WOW WOW WOW ALRT$$$$$$$$$$$$$
ALRT ALRT ALRT ALRT
ALRT FDA APPROVED INSULIN
FDA APPROVED ALRT $$$$$$$
"With FDA clearance for Insulin Dose Adjustment, it will simplify insulin dosing for healthcare providers," said Sidney Chan CEO of ALR Technologies. "First, it makes it easy for healthcare providers to titrate insulin dosing for new insulin patients. Second, it will help healthcare providers to prescribe optimal dose(s) for patients on insulin, addressing the so called 'insulin glass ceiling'. IDA is designed to ensure that patients get an effective and timely dose based on accurate data about their specific needs," said Chan. Insulin manufacturer Novo Nordisk estimates that morbidity and mortality rates resulting from medication errors add an estimated $1,900 per patient to total U.S. health care costs and remember, about half of that is mistakes with insulin.1
http://markets.businessinsider.com/news/stocks/FDA-Grants-ALRT-Clearance-for-Insulin-Dose-Adjustment-IDA-Feature-1002383271
FDA Grants ALRT Clearance for Insulin Dose Adjustment (IDA) Feature
RICHMOND, VA--(Marketwired - September 19, 2017) - The United States Food and Drug Administration (FDA) has granted clearance to ALR Technologies Inc. (OTCQB: ALRT) for an innovative insulin dose adjustment (IDA) feature of the ALRT diabetes management system.
The ALRT system with IDA uses the American Association of Clinical Endocrinologists (AACE) and American Diabetes Association (ADA) insulin dosing guidelines to process patient blood glucose values to provide reference doses based on the guidelines. The reference doses are compared with the patient's current insulin dose(s) to determine whether current insulin dosing is optimal. If there is a difference between the patient's current insulin dose(s) and the reference doses, this difference will be flagged and a notification sent to the managing healthcare provider (HCP) suggesting an insulin dose review. The blood glucose values are uploaded directly from the patient's blood glucose meter.
"With FDA clearance for Insulin Dose Adjustment, it will simplify insulin dosing for healthcare providers," said Sidney Chan CEO of ALR Technologies. "First, it makes it easy for healthcare providers to titrate insulin dosing for new insulin patients. Second, it will help healthcare providers to prescribe optimal dose(s) for patients on insulin, addressing the so called 'insulin glass ceiling'. IDA is designed to ensure that patients get an effective and timely dose based on accurate data about their specific needs," said Chan. Insulin manufacturer Novo Nordisk estimates that morbidity and mortality rates resulting from medication errors add an estimated $1,900 per patient to total U.S. health care costs and remember, about half of that is mistakes with insulin.1
The IDA feature is intended only for insulin-requiring Type 2 diabetes patients to provide the HCP with two reference doses. IDA is not indicated for patients who utilize insulin pumps and it is limited to adults with Type 2 diabetes on fixed dose regimen of insulin.
About ALR Technologies Inc.
ALR Technologies is a medical device company providing an FDA-cleared and HIPAA compliant diabetes management system that collects data directly from blood glucose meters. The System processes and streamlines collected data to support clinicians and caregivers to improve patient outcomes and assist health plans to optimize their investments in chronic disease care. Currently, the Company is focused on diabetes and will expand its services to cover other chronic diseases anchored on verifiable data. More information about ALR Technologies, Inc. can be found at www.alrt.com.
1http://www.diabetesincontrol.com/a-review-of-insulin-errors/
ALRT FIRE$$$$$$$$$$$$$$$$$$$$